12th November 2021
Nuformix plc (LSE: NFX), a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing, announces that it has filed a new patent application in relation to NXP004.
Download News12th November 2021
Nuformix plc (LSE: NFX), a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing, announces that it has filed a new patent application in relation to NXP004.
Download News